JITC

Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective – a SENTICOL ancillary study
Gaurav Thareja, Anna Salvioni, Françoise Lauzeral-Vizcaino, Najeeb Halabi, Eliane Mery-Lamarche, Noemie Thebault, Clara-Maria Scarlata, Marie Michelas, Anne-Sophie Navarro, Gwenaël Ferron, Fabrice Lecuru, Patrice Mathevet, Jonathan Khalifa, Maha Ayyoub, Arash Rafii, Alejandra Martinez

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008734; DOI: 10.1136/jitc-2023-008734
Novel insights into paclitaxel’s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment
Yoonjeong Choi, Seong A Kim, Hanul Jung, Eunhae Kim, Yoon Kyoung Kim, Seohyun Kim, Jaehyun Kim, Yeji Lee, Min Kyoung Jo, Jiwan Woo, Yakdol Cho, Dongjoo Lee, Hongyoon Choi, Cherlhyun Jeong, Gi-Hoon Nam, Minsu Kwon, In-San Kim

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008864; DOI: 10.1136/jitc-2024-008864
Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species
Man Zhu, Wenjun Tang, Xiaoyu Tang, Zeren Zhu, Yina Jiang, Ammar Sarwar, Hongmei Zhang, Dake Chu, Zixi Zhang, Yanmin Zhang

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009099; DOI: 10.1136/jitc-2024-009099
A crisis in clinical research
David S Hong, Patricia LoRusso, Mario Sznol

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008520; DOI: 10.1136/jitc-2023-008520
Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors
Juan Chen, Jia-Si Liu, Jun-Yan Liu, Lei She, Ting Zou, Fan Yang, Xiang-Ping Li, Zhan Wang, Zhaoqian Liu

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009399; DOI: 10.1136/jitc-2024-009399
Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma
Yang Chen, Yu Zhou, Ran Ren, Yu Chen, Juan Lei, Yongsheng Li

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008811; DOI: 10.1136/jitc-2024-008811
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines
Jeffrey Schlom, Renee N Donahue, Claudia Palena, Sofia R Gameiro, James W Hodge, Duane H Hamilton, James L Gulley

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009595; DOI: 10.1136/jitc-2024-009595
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids
Elias Burri, Joanna Mangana, Phil F Cheng, Alia Schneider, Achim Weber, Reinhard Dummer, Egle Ramelyte

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008074; DOI: 10.1136/jitc-2023-008074
TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response
Saraí G De León-Rodríguez, Cristina Aguilar-Flores, Julián A Gajón, Ángel Juárez-Flores, Alejandra Mantilla, Raquel Gerson-Cwilich, José Fabián Martínez-Herrera, Diana Alejandra Villegas-Osorno, Claudia T Gutiérrez-Quiroz, Sergio Buenaventura-Cisneros, Mario Alberto Sánchez-Prieto, Edmundo Castelán-Maldonado, Samuel Rivera Rivera, Ezequiel M Fuentes-Pananá, Laura C Bonifaz

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008739; DOI: 10.1136/jitc-2023-008739
Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin
Liuhai Zheng, Huifang Wang, Jihao Zhou, Guangwei Shi, Jingbo Ma, Yuke Jiang, Zhiyu Dong, Jiexuan Li, Yuan-Qiao He, Dinglan Wu, Jichao Sun, Chengchao Xu, Zhijie Li, Jigang Wang

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008888; DOI: 10.1136/jitc-2024-008888

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages